A COVID-19 Risk Reduction Strategy for the Treatment of Acute Vogt-Koyanagi-Harada Disease Utilizing the Antiviral Potential of Cyclosporine.

Nakayama, Makiko; Okada, Annabelle A; Hayashi, Isami; Ando, Yoshimasa; Watanabe, Takayo; Keino, Hiroshi

Nakayama, Makiko; Okada, Annabelle A; Hayashi, Isami; Ando, Yoshimasa; Watanabe, Takayo; Keino, Hiroshi.

Afiliación

Nakayama M; Department of Ophthalmology, Kyorin University School of Medicine, Tokyo, Japan.
Okada AA; Department of Ophthalmology, Kyorin University School of Medicine, Tokyo, Japan.
Hayashi I; Department of Ophthalmology, Kyorin University School of Medicine, Tokyo, Japan.
Ando Y; Department of Ophthalmology, Kyorin University School of Medicine, Tokyo, Japan.
Watanabe T; Department of Ophthalmology, Kyorin University School of Medicine, Tokyo, Japan.
Keino H; Department of Ophthalmology, Kyorin University School of Medicine, Tokyo, Japan.

Ocul Immunol Inflamm ; 31(2): 462-467, 2023 Feb.

Article en En | MEDLINE | ID: mdl-35167414

Asunto(s)

COVID-19; Síndrome Uveomeningoencefálico; Humanos; Anciano; Triamcinolona Acetonida/uso terapéutico; Ciclosporina/uso terapéutico; Síndrome Uveomeningoencefálico/diagnóstico; Síndrome Uveomeningoencefálico/tratamiento farmacológico; Síndrome Uveomeningoencefálico/inducido químicamente; Glucocorticoides/uso terapéutico; Estudios Retrospectivos; Pandemias

Palabras clave

COVID-19; Coronavirus; Vogt-Koyanagi-Harada Disease; cyclosporine; triamcinolone acetonide

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Síndrome Uveomeningoencefálico / COVID-19 Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Aged / Humans Idioma: En Revista: Ocul Immunol Inflamm Asunto de la revista: ALERGIA E IMUNOLOGIA / OFTALMOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Japón

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google